Adenocarcinoma of the Pancreas Completed Phase 2 Trials for Gemcitabine (DB00441)

Also known as: Pancreatic adenocarcinoma / Adenocarcinoma Pancreas / Pancreas, Adenocarcinoma / Pancreas Adenocarcinoma / Adenocarcinoma of Pancreas / Adenocarcinoma, Pancreas

IndicationStatusPhase
DBCOND0029532 (Adenocarcinoma of the Pancreas)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00609336Combination Chemotherapy, Intensity-Modulated Radiation Therapy, and Surgery in Treating Patients With Localized Pancreatic Cancer That Can Be Removed By SurgeryTreatment
NCT00577889Gemcitabine Hydrochloride and Tanespimycin in Treating Patients With Stage IV Pancreatic CancerTreatment
NCT00366457Gemcitabine, Bevacizumab and Erlotinib in Pancreatic CancerTreatment
NCT00114179Capecitabine, Bevacizumab, and Radiation Therapy Followed By Gemcitabine and Bevacizumab in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed By SurgeryTreatment
NCT00096070Radiotherapy Combined With Oxaliplatin and Fluorouracil Followed By Gemcitabine in Treating Patients With Locally Advanced, Unresectable Pancreatic CancerTreatment
NCT00095966Sorafenib and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Pancreatic CancerTreatment
NCT00091026Bevacizumab and Gemcitabine Combined With Either Cetuximab or Erlotinib in Treating Patients With Advanced Pancreatic CancerTreatment
NCT00026104Combination Chemotherapy Plus Radiation Therapy With or Without Tipifarnib in Treating Patients With Locally Advanced Pancreatic CancerTreatment
NCT00028834Bevacizumab and Gemcitabine in Treating Patients With Advanced Pancreatic CancerTreatment
NCT00020345Combination Chemotherapy and Radiation Therapy Plus Surgery in Treating Patients With Advanced Cancer of the PancreasTreatment
NCT01839799A Randomized Phase II/Genomic Trial of Two Chemotherapy Regimens in Patients With Resected Pancreatic AdenocarcinomaTreatment
NCT01389440Efficacy and Safety of a Neoadjuvant Treatment in Pancreatic CancerTreatment
NCT01144455Study of the Safety and Efficacy of TH-302 in Combination With Gemcitabine Compared With Gemcitabine Alone in Previously Untreated Patients With Pancreatic AdenocarcinomaTreatment